Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

OTC Markets OTCPK - Delayed Quote USD

HYTN INNOVATIONS INC. (HYTNF)

Compare

0.1500

0.0000

(0.00%)

As of March 5 at 3:00:00 PM EST. Market Open.

HYTN Launches GMP Stability Program and Validates Vape Cartridges for International Markets

VANCOUVER, British Columbia, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or the "Company"), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce the launch of its Good Manufacturing Practice (GMP) Stability Program and the validation of its cannabis vape cartridges for international distribution. This initiative builds upon HYTN’s January 21, 2025, announcement of its strategic partnership with SNDL Inc. to de

GlobeNewswire 15 days ago

HYTNF
0.00%
HYTN and A1 Cannabis Announce Collaboration Agreements to Scale Production of Cannabis Products

VANCOUVER, British Columbia, Feb. 17, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a company specializing in pharmaceutical-grade cannabis manufacturing, is pleased to announce that it has entered into a comprehensive collaboration (the “Collaboration”) with A1 Cannabis Inc. (“A1”), owner of Summit Cannabis Beverages ("Summit"). Through the Collaboration, the Company and A1 seek to enhance operational efficiency and expand both

GlobeNewswire 16 days ago

HYTNF
0.00%
HYTN and SNDL to Collaborate on GMP-Compliant Vape Cartridge Development for Global Markets

VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a company specializing in pharmaceutical-grade cannabis manufacturing, is pleased to announce that it has entered into a collaboration agreement (the Agreement) with SNDL Inc. (NASDAQ: SNDL) ("SNDL"), one of the world’s largest vertically integrated cannabis companies, to jointly develop Good Manufacturing Practices (GMP) compliant vape cartridge

GlobeNewswire last month

HYTNF
0.00%
SNDL
HYTN Secures Additional Permits to Expand International GMP Cannabis Exports

VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical company specializing in pharmaceutical-grade cannabis manufacturing is pleased to announce that it has received a new set of import permits from the United Kingdom’s Home Office and corresponding export permits from Health Canada. These permits enable the fulfillment of international orders totaling over 400 kilograms of Good Man

GlobeNewswire last month

HYTNF
0.00%
HYTN Announces Initial Purchase Order under Manufacturing Partnership with Industry-Leading SNDL

VANCOUVER, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical company specializing in pharmaceutical-grade cannabis manufacturing is pleased to announce the receipt of an initial purchase order under manufacturing and pricing agreements (the Agreements) with SNDL Inc. (NASDAQ: SNDL) ("SNDL"), one of the world’s largest vertically integrated cannabis companies. This collaboration underscores

GlobeNewswire last month

HYTNF
0.00%
SNDL
HYTN Announces Sale and Distribution of GMP Cannabis Products in the UK

Products now accessible to UK patients, with over 500 kilograms of additional orders in productionVANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or "the Company"), a pharmaceutical company specializing in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce its successful export of cannabis to the United Kingdom’s 4

GlobeNewswire 2 months ago

HYTNF
0.00%
HYTN Receives Opening Order and Import Permits from the UK's 4C Labs, Prepares Products for Export

VANCOUVER, British Columbia, Nov. 28, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce the receipt of initial orders and import permits from the UK's 4C Labs, marking a significant milestone in their partnership. This achievement allows HYTN to

GlobeNewswire 3 months ago

HYTNF
0.00%
HYTN Announces Marketing Program

VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a company specializing in the pharmaceutical development and production of psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce that it has engaged bullVestor Medien GmbH (“bullVestor”) (address: Gutenhofen 4, 4300, St. Valentin, Austria email: kontakt@bullvestor.at) to provide marketing services for

GlobeNewswire 3 months ago

HYTNF
0.00%
HYTN Expands GMP Capabilities with New Licensed Activity

HYTN receives certification for GMP distribution to international marketsVANCOUVER, British Columbia, Oct. 09, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabis and psilocybin, proudly announces that it has received an additional Good Manufacturing Practices (“GMP”) certification for

GlobeNewswire 4 months ago

HYTNF
0.00%
HYTN Files Business Acquisition Report

VANCOUVER, British Columbia, Sept. 27, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabinoids and psilocybin, is pleased to announce, further to its news release dated July 19, 2024, that it has filed a Business Acquisition Report (BAR) in respect of its acquisition of Prism Scientifi

GlobeNewswire 5 months ago

85W0.F

HYTN.CN

HYTNF
0.00%
HYTN Partners with the UK's 4C Labs, Validates GMP Certification

VANCOUVER, British Columbia, Sept. 10, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabinoids and psilocybin, is proud to announce the establishment of international manufacturing and pricing agreements (the Agreements) with 4C LABS, a leading importer and distributor of cannabis-base

GlobeNewswire 5 months ago

HYTNF
0.00%
HYTN.CN

85W0.F
HYTN Lists on the OTC Pink Market

VANCOUVER, British Columbia, July 29, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0 | OTC PINK: HYTNF) “HYTN” or “the Company”, a pharmaceutical company specializing in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce its approval for trading on the OTC PINK Market ("OTC PINK") effective July 29th, 2024, under the trading symbol “HYTNF”. Elliot McKerr,

GlobeNewswire 7 months ago

HYTN.CN

85W0.F

HYTNF
0.00%
HYTN Completes Acquisition of Prism Scientific Labs, Enhancing Psychedelic Compound Manufacturing Capabilities

VANCOUVER, British Columbia, July 19, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0) "HYTN" or "The Company", a leader in the development, formulation, and manufacturing of psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce, further to its news release dated June 13, 2024, the completion of its acquisition (“Acquisition”) of all of the issued and outstanding share capital of Prism Scientific Labs Inc. (Prism), a company focu

GlobeNewswire 7 months ago

85W0.F

HYTN.CN

HYTNF
0.00%
HYTN Awarded Drug Establishment License from Health Canada, Expanding GMP Capabilities

"One of the very few companies globally to achieve these certifications"VANCOUVER, British Columbia, June 27, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN | FSE: 85W0) “HYTN” or “The Company”, a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis and psilocybin, is pleased to announce that it has been granted a Drug Establishment License (DEL) by Health Canada. This license allows HYTN to engage

GlobeNewswire 8 months ago

85W0.F

HYTNF
0.00%
HYTN.CN

Performance Overview

Return	HYTNF	S&P/TSX Composite index
YTD	-6.25%	+0.51%
1-Year	-45.55%	+14.97%
3-Year	-45.55%	+15.63%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

HYTN INNOVATIONS INC. (HYTNF)

HYTN Launches GMP Stability Program and Validates Vape Cartridges for International Markets

HYTN and A1 Cannabis Announce Collaboration Agreements to Scale Production of Cannabis Products

HYTN and SNDL to Collaborate on GMP-Compliant Vape Cartridge Development for Global Markets

HYTN Secures Additional Permits to Expand International GMP Cannabis Exports

HYTN Announces Initial Purchase Order under Manufacturing Partnership with Industry-Leading SNDL

HYTN Announces Sale and Distribution of GMP Cannabis Products in the UK

HYTN Receives Opening Order and Import Permits from the UK's 4C Labs, Prepares Products for Export

HYTN Announces Marketing Program

HYTN Expands GMP Capabilities with New Licensed Activity

HYTN Files Business Acquisition Report

HYTN Partners with the UK's 4C Labs, Validates GMP Certification

HYTN Lists on the OTC Pink Market

HYTN Completes Acquisition of Prism Scientific Labs, Enhancing Psychedelic Compound Manufacturing Capabilities

HYTN Awarded Drug Establishment License from Health Canada, Expanding GMP Capabilities

Performance Overview